Freier DT, Mcleod MK

Language: English
References: 18
Page: 232-235
PDF size: 147.29 Kb.

ABSTRACT

Objective: The purpose is to bring attention to the continuing changes occurring in pheochro-mocytoma diagnosis, localization, blockade of its physiological effects, surgical excision, and management of recurrences.
Data collection: This is a review on the development of the identification and treatment of a rare but interesting tumor of chromaffin tissue that occurs throughout the body. The data is taken from highly selected references (18 references).
Results: An efficient screening technique for diagnosis, has not yet been developed. Sophisticated urinary and plasma studies are required. Localization has advanced remarkably with computerization of radiographic techniques and nuclear scanning. Blockade is very important, especially if laparoscopic excision is contemplated. The are few complications from it. Surgical excision has dramatically changed with laparoscopic techniques. Many recurrences respond to chemotherapy and nuclear medication obliteration after debulking.
Conclusion: Our overall conclusion is that treatment of this tumor requires constant study because all aspects are quickly changing as technology progresses.

REFERENCES

1. McLeod MK. Adrenal incidentaloma. Acta Chirurg Austriaca 1993; 25: 202.

2. Werbel SS, Over KP. Pheochromocytoma. Update on diagnosis, localization, and management. Med Clin North Am 1995; 79: 131-53.

3. Heron E, Chatellier G, Billaud E, Foos E, Plouin PF. The urinary metanefrine to diagnosis of pheochromocytoma [see comments]. Ann Intern Med 1996; 125: 300-3.

4. Freier DT, Harrison TS. Rigorous biochemical criteria for the diagnosis of pheochromocytoma. J Surg Res 1973; 14: 177-80.

5. Lenders JW, Keiser HR, Goldstein DS, Willemsen JJ, Friberg P, Jacobs MC, et al. Plasma metanephrines in the diagnosis of pheochromocytoma [see comments]. Ann Intern Med 1995; 123: 101-9.

6. Shapiro B, Sisson JC, Shulkin BL, Gross MD, Zempel S. The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors. Q J Nucl Med 1995; 39(4 suppl 1): 3-8.

7. Peplinski GR, Morton JA. The predictive value of diagnostic tests for pheochromocytoma. Surgery 1994; 116: 1101-9; discussion 1109-10.

8. Schwerk WB, Gorg C, Gorg K, Restrepo IK. Adrenal pheochromocytoma: a broad spectrum of sonographic presentation. J Ultrasound Med 1994; 13: 517-21.

9. Freier DT, Thompson NW. Pheochromocytoma and pregnancy: The epitome of high risk. Surgery 1993; 114: 1148-52.

10. Proye C, Thevenin D, Cecat P, Pettilot P, Carnaille B, Verin P, et al. Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: Hemodynamics and free catecholamine assays in ten consecutive patients. Surgery 1989; 106: 1149-54.

11. Munro J, Hurlbert BJ, Hill GE. Calcium channel blockade and uncontrolled blood pressure during pheochromocytoma surgery. Can J Anaesth 1995; 42: 228-30.

12. Duh QY, Siperstein AE, Clark OH, Schecter WP, Horn JK, Harrison MR, et al. Laparoscopic adrenalectomy. Comparison of the lateral and posterior approach. Arch Surg 1996; 131: 870-5; discussion 867-9.

13. Gagner M, Breton G, Pharand DJ. Pomp A. Is laparoscopic adrenalectomy indicated for pheochromocytomas? Surgery 1996; 120: 1076-9; discussion 1079-80.

14. Orchard T, Grant CS, van Heerden JA, Weaver A. Pheochromocytoma continuing evolution of surgical therapy. Surgery 1993; 114: 1153-8; discussion 1158-9.

15. Obara T, Kanbe M, Okamoto T, Ito Y, Yamashita T, Ito K, et al. Surgical strategy for pheochromocytoma: emphasis on the pledge of flank extraperitoneal approach in selected patients. Surgery 1995; 118: 1083-9.

16. Irvin GL 3rd, Fishman LM, Sher JA, Yeung LK, Irani H. Pheochromocytoma: lateral versus anterior operative approach. Ann Surg 1989; 209: 774-8; discussion 778.

17. Shapiro B, Sisson JC, Shulkin BL, Gross MD, Zempel S. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors. Q J Nucl Med 1995; 39(4 suppl 1): 55-7.

18. Averbuch SD, Steakley CS, Young RC, Gelman EP, Goldstein DS, Stull R, et al. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 1988; 109: 267-73.